NCT01193504View on ClinicalTrials.gov

Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification

PHASE4UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
PseudophakiaCataract Surgery
Interventions
DRUG

Pred Forte

Pred Forte BID for 4 weeks postop

DRUG

Lotemax

Lotemax BID for 4 weeks postop.

Trial Locations (3)

33176

RECRUITING

The Center For Excellence in Eye care, Miami

92653

RECRUITING

Harvard Eye Associates, Laguna Hills

02451

COMPLETED

Ophthalmic Consultants of Boston, Waltham

Sponsors

Lead Sponsor

Innovative Medical
All Listed Sponsors
lead

Innovative Medical

INDUSTRY